Genoray Co., Ltd. (KOSDAQ:122310)
4,720.00
-10.00 (-0.21%)
At close: Apr 17, 2026
Genoray Market Cap
Genoray has a market cap or net worth of 57.34 billion as of April 17, 2026. Its market cap has decreased by -19.77% in one year.
Market Cap
57.34B
Enterprise Value
73.96B
Revenue
108.04B
Ranking
n/a
PE Ratio
77.38
Stock Price
4,720.00
Market Cap Chart
Since May 28, 2018, Genoray's market cap has decreased from 150.47B to 57.34B, a decrease of -61.90%. That is a compound annual growth rate of -11.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 57.34B | 13.46% |
| Dec 30, 2025 | 50.53B | -27.84% |
| Dec 30, 2024 | 70.03B | -26.75% |
| Dec 28, 2023 | 95.60B | -11.63% |
| Dec 29, 2022 | 108.18B | -23.55% |
| Dec 30, 2021 | 141.51B | 1.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| May 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Remed | 98.28B |
| Noul Co.,Ltd. | 89.20B |
| Neofect | 86.73B |
| QuantaMatrix | 83.76B |
| Hironic | 74.74B |
| JPI Healthcare | 64.84B |
| DRGEM | 62.10B |
| MEKICS CO., | 50.13B |